Tag Archives: Companion Diagnostics

OmniSeq, an innovation of Roswell Park Cancer Institute, announced today the commercial launch of Immune Report Card SM, the first immune profiling test designed to help oncologists select the best mono and combination immunotherapy options for their patients. The assay ...

Illumina Acquires Myraqa, a Leading IVD and Companion Diagnostic Consulting Firm Acquisition Strengthens Illumina’s Clinical Readiness SAN DIEGO–(BUSINESS WIRE)–Jul. 16, 2014– Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Myraqa, a regulatory and quality consulting firm specializing in IVDs, ...